Extracellular Vesicles as Novel Diagnostic and Therapeutic Agents for Non-Melanoma Skin Cancer: A Systematic Review

Konstantinos Seretis1, Eleni Boptsi1, Anastasia Boptsi1

  • 1Department of Plastic Surgery, Medical School, University of Ioannina, 45100 Ioannina, Greece.

Insights

Non-melanoma skin cancer (NMSC) derived extracellular vesicles (EVs) show potential as diagnostic biomarkers and therapeutic targets. Further research is needed to understand their role in NMSC progression and treatment.

Area of Science:

  • Oncology
  • Biochemistry
  • Cell Biology

Background:

  • Standard non-melanoma skin cancer (NMSC) treatments include surgery, chemotherapy, and immunotherapy for advanced cases.
  • Extracellular vesicles (EVs), including exosomes, play a role in cancer development and are found in NMSC, releasing mediators that influence tumor progression.
  • The exact intercellular signaling function of NMSC-derived EVs is not fully understood.

Approach:

  • This systematic review analyzed literature from database inception to September 2023.
  • Inclusion and exclusion criteria were applied to studies focusing on NMSC-derived EVs, their molecular cargo, and their diagnostic, prognostic, and therapeutic implications.
  • Key molecular components within NMSC-derived EVs were identified.

Key Points:

  • EV proteins and RNA show promise as diagnostic biomarkers for NMSC through liquid biopsy.
  • Circular RNA CYP24A1 is a stable diagnostic biomarker candidate.
  • Long noncoding RNAs (lincRNA-PICSAR) and Desmoglein 2 (DSg2) are prognostic biomarkers linked to drug resistance.
  • EV mediators are being explored as potential drug delivery agents.

Conclusions:

  • NMSC-derived EVs represent promising therapeutic targets and diagnostic biomarkers.
  • Further investigation into EV mechanisms is crucial for advancing NMSC diagnosis and treatment strategies.

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K